Pamela L. Rice
Veterans Affairs Medical Center; Denver
USA
Name/email consistency: high
- Sulindac independently modulates extracellular signal-regulated kinase 1/2 and cyclic GMP-dependent protein kinase signaling pathways. Rice, P.L., Peters, S.L., Beard, K.S., Ahnen, D.J. Mol. Cancer Ther. (2006)
- Inhibition of extracellular-signal regulated kinases 1/2 is required for apoptosis of human colon cancer cells in vitro by sulindac metabolites. Rice, P.L., Beard, K.S., Driggers, L.J., Ahnen, D.J. Cancer Res. (2004)
- Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells. Rice, P.L., Kelloff, J., Sullivan, H., Driggers, L.J., Beard, K.S., Kuwada, S., Piazza, G., Ahnen, D.J. Mol. Cancer Ther. (2003)